Clinical Trials Sponsored by Duda

Total 174 results

Fuda Cancer Hospital, Guangzhou
University of Michigan

Completed

Safety Study of Cancer Stem Cell Vaccinie to Treat Breast Cancer (CSC)

Neoplasms, Breast

China
Fuda Cancer Hospital, Guangzhou
University of Michigan

Completed

Cancer Stem Cells Vaccine Therapy in Treating Hepatocellular Cancer Patients

Neoplasms, Liver

China
Hywel Dda Health Board
Swansea University

Completed

sTep dOWn Inhalers in the reAl woRlD (TOWARD)

Chronic Obstructive Pulmonary Disease

United Kingdom
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Cryosurgery and NK Immunotherapy for Tumors in Transplanted Liver

Liver Tumor | Evidence of Liver Transplantation

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

High-activity Natural Killer Immunotherapy for Small Metastases of Tongue Cancer

Tongue Cancer

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Cryosurgery and NK Immunotherapy for Advanced Esophageal Cancer

Metastatic Esophageal Cancer

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Cryosurgery and NK Immunotherapy for Advanced Liver Cancer

Secondary Malignant Neoplasm of Liver

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Irreversible Electroporation and NK Immunotherapy for Recurrent Liver Cancer

Recurrent Liver Carcinoma

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Cryosurgery and NK Immunotherapy for Advanced Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer Metastatic

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Cryosurgey and NK Immunotherapy for Recurrent Pharyngeal Cancer

Recurrent Pharyngeal Cancer

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Cryosurgery and NK Immunotherapy for Recurrent Sarcoma

Recurrent Adult Soft Tissue Sarcoma

China
Fuda Cancer Hospital, Guangzhou
Shengxin Biotechnology Institute, Beijing

Completed

Bioinformation Therapy for Intestinal Cancer

Advanced Intestinal Cancer

China
Fuda Cancer Hospital, Guangzhou
Shengxin Biotechnology Institute, Beijing

Completed

Bioinformation Therapy for Pancreatic Cancer

Unresectable Pancreatic Cancer

China
Fuda Cancer Hospital, Guangzhou
Shengxin Biotechnology Institute, Beijing

Completed

Bioinformation Therapy for Gastric Cancer

Advanced Gastric Cancer

China
Goldman, Butterwick, Fitzpatrick and Groff
DUSA Pharmaceuticals, Inc.

Completed

A Clinical Trial Evaluating the Role of Systemic Antihistamine Therapy in the Reduction of Adverse Effects Associated With Topical 5-aminolevulinic Acid Photodynamic Therapy

Actinic Keratoses

United States
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Bevacizumab and Allogeneic NK Immunotherapy for Metastatic Solid Tumors

Malignant Solid Tumour

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Anti-PD-1 and NK Immunotherapy for Recurrent Solid Tumors

Malignant Solid Tumour

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Rituximab and NK Immunotherapy for B Lymphoma

B-cell Lymphoma Recurrent

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Cryosurgey and NK Immunotherapy for Recurrent Ovarian Cancer

Recurrent Ovarian Cancer

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

High-activity Natural Killer Immunotherapy for Small Metastases of Melanoma

Melanoma

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

High-activity Natural Killer Immunotherapy for Small Metastases of Pancreatic Cancer

Pancreatic Cancer

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Cryosurgery and NK Immunotherapy for Advanced Kidney Cancer

Metastatic Renal Cell Cancer

China
Fuda Cancer Hospital, Guangzhou
Shengxin Biotechnology Institute, Beijing

Completed

Bioinformation Therapy for Lung Cancer

Small-cell Lung Cancer

China
Aberystwyth University
Hywel Dda Health Board

Completed

Optimisation of Exercise Intensity During High-Intensity Interval Training for Glucose Control in Prediabetes

PreDiabetes

United Kingdom
Aberystwyth University
Hywel Dda Health Board

Completed

15-minute Individual Consultation to Improve Blood Glucose Control in Pre-diabetes

Pre-Diabetes

United Kingdom
Aberystwyth University
Hywel Dda Health Board

Completed

Do Educational Digital Films Enhance Patient COPD Outcomes?

Chronic Obstructive Pulmonary Disease

United Kingdom
University of Alabama at Birmingham
DUSA Pharmaceuticals, Inc.

Completed

Blue Light Photodynamic Therapy Treatment for Distal and Lateral Subungual Toenail Onychomycosis

Toenail Onychomycosis | Distal and Lateral Subungual Toenail Onychomycosis

United States
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Cryosurgey and NK Immunotherapy for Recurrent Tongue Cancer

Recurrent Tongue Cancer

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Trastuzumab and NK Immunotherapy for Recurrent Breast Cancer

Recurrent Breast Cancer

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic Cancer

Pancreatic Cancer

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Cetuximab and NK Immunotherapy for Recurrent Non-small Cell Lung Cancer

Recurrent Non-small Cell Lung Cancer

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Cryosurgey and NK Immunotherapy for Recurrent Laryngeal Cancer

Recurrent Laryngeal Cancer

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Comparison of Autogenic and Allogenic NK Immunotherapy on the Outcome of Recurrent Solid Tumors

Malignant Solid Tumour

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

High-activity Natural Killer Immunotherapy for Small Metastases of Non-small Cell Lung Cancer

Non-small Cell Lung Cancer Metastatic

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Cryosurgey and NK Immunotherapy for Recurrent Cervical Cancer

Recurrent Cervical Cancer

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Cryosurgery and NK Immunotherapy for Advanced Breast Cancer

Breast Cancer Recurrent

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

High-activity Natural Killer Immunotherapy for Small Metastases of Nasopharyngeal Cancer

Metastatic Nasopharyngeal Cancer

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

High-activity Natural Killer Immunotherapy for Small Metastases of Colorectal Cancer

Metastatic Colorectal Cancer

China
Fuda Cancer Hospital, Guangzhou
Shengxin Biotechnology Institute, Beijing

Completed

Bioinformation Therapy for Liver Cancer

Liver, Cancer of, Non-Resectable

China
Fuda Cancer Hospital, Guangzhou
Shengxin Biotechnology Institute, Beijing

Completed

Bioinformation Therapy for Breast Cancer

Advanced Breast Cancer

China
Duta Wacana Christian University
PT SOHO Global Health Tbk

Unknown

The Benefits of Astaxanthin as Add on Therapy in the Management of Painful Diabetic Neuropathy Patient

Painful Diabetic Neuropathy

Indonesia
Fuda Cancer Hospital, Guangzhou
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.

Withdrawn

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Kidney Cancer

Advanced Kidney Cancer

China
Fuda Cancer Hospital, Guangzhou
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.

Withdrawn

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Lung Cancer

Advanced Lung Cancer

China
Fuda Cancer Hospital, Guangzhou
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.

Withdrawn

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Pancreatic Cancer

Advanced Pancreatic Cancer

China
Duta Wacana Christian University
PT SOHO Global Health Tbk

Unknown

The Benefits of Vitamin B Combination as Add on Therapy in the Management of Painful Diabetic Neuropathy Patient

Painful Diabetic Neuropathy

Indonesia
Fuda Cancer Hospital, Guangzhou
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.

Withdrawn

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Liver Cancer

Advanced Liver Cancer

China
Fuda Cancer Hospital, Guangzhou
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.

Withdrawn

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Colorectal Cancer

Advanced Colorectal Cancer

China
Duta Wacana Christian University
Dexa Laboratories Of Biomolecular Science

Unknown

The Benefit of Add On DLBS1033 for Ischemic Stroke Patient

Ischemic Stroke

Indonesia
Duta Wacana Christian University
PT SOHO Global Health Tbk

Unknown

The Benefits of Vitamin D 5000 IU as Add on Therapy in the Management of Painful Diabetic Neuropathy Patient

Painful Diabetic Neuropathy

Indonesia
Fuda Cancer Hospital, Guangzhou
Shanghai Asclepius Meditech Co., Ltd

Completed

Hydrogen Gas for Cancer Rehabilitation

Adult Solid Tumor

China

Clinical Trials Sponsored by Duda

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sri Lanka

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations